PL2848681T4 - Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki - Google Patents

Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki

Info

Publication number
PL2848681T4
PL2848681T4 PL14190638T PL14190638T PL2848681T4 PL 2848681 T4 PL2848681 T4 PL 2848681T4 PL 14190638 T PL14190638 T PL 14190638T PL 14190638 T PL14190638 T PL 14190638T PL 2848681 T4 PL2848681 T4 PL 2848681T4
Authority
PL
Poland
Prior art keywords
faeces
strains
characterization
isolation
identification
Prior art date
Application number
PL14190638T
Other languages
English (en)
Other versions
PL2848681T3 (pl
Inventor
Fernández José María Vieites
Quezada Sergio Muñoz
Company Inmaculada Llamas
Lozano José Maldonado
Braquehais Fernando Romero
García Antonio Francisco Suárez
Hernández Ángel Gil
Llorente Carolina Gómez
Brito Miriam Bermúdez
Original Assignee
Hero Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hero Ag filed Critical Hero Ag
Publication of PL2848681T3 publication Critical patent/PL2848681T3/pl
Publication of PL2848681T4 publication Critical patent/PL2848681T4/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
PL14190638T 2009-03-10 2010-03-09 Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki PL2848681T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/ES2009/000130 WO2010103132A1 (es) 2009-03-10 2009-03-10 Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
EP14190638.8A EP2848681B1 (en) 2009-03-10 2010-03-09 Isolation, identification and characterization of strains with probiotic activity from the faeces of babies fed exclusively with breast milk
EP10750390.6A EP2407532B1 (en) 2009-03-10 2010-03-09 Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk

Publications (2)

Publication Number Publication Date
PL2848681T3 PL2848681T3 (pl) 2017-10-31
PL2848681T4 true PL2848681T4 (pl) 2017-10-31

Family

ID=42727821

Family Applications (3)

Application Number Title Priority Date Filing Date
PL14190648T PL2848682T3 (pl) 2009-03-10 2010-03-09 Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki
PL10750390T PL2407532T3 (pl) 2009-03-10 2010-03-09 Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym pochodzących z kału niemowląt karmionych wyłącznie mlekiem matki
PL14190638T PL2848681T4 (pl) 2009-03-10 2010-03-09 Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL14190648T PL2848682T3 (pl) 2009-03-10 2010-03-09 Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki
PL10750390T PL2407532T3 (pl) 2009-03-10 2010-03-09 Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym pochodzących z kału niemowląt karmionych wyłącznie mlekiem matki

Country Status (8)

Country Link
US (3) US8637297B2 (pl)
EP (3) EP2407532B1 (pl)
CN (3) CN102421889B (pl)
DK (3) DK2848681T3 (pl)
ES (3) ES2532095T3 (pl)
PL (3) PL2848682T3 (pl)
RU (1) RU2551315C2 (pl)
WO (2) WO2010103132A1 (pl)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
NZ580006A (en) * 2007-03-28 2012-03-30 Alimentary Health Ltd Probiotic bifidobacterium strain 41387
CA2807242C (en) 2010-08-04 2017-05-02 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
BR112013022927A2 (pt) 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
RU2453591C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии
KR101228035B1 (ko) * 2011-06-29 2013-01-30 주식회사 쎌바이오텍 신규한 유산균 및 이를 포함하는 당뇨병 예방 및 치료용 조성물
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
BR112015010698A2 (pt) * 2012-11-12 2017-07-11 Gervais Danone Sa uso de uma linhagem de lactobacillus rhamnosus para a redução de ganho de peso e/ou de resistência a insulina
ES2468040B1 (es) * 2012-11-13 2014-12-26 Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria (Inia) Microorganismo aislado de leche materna y de heces de un lactante, y su uso como probiótico
CN102960599A (zh) * 2012-11-19 2013-03-13 陕西科技大学 一种含益生元的双歧杆菌微胶囊的制备方法
ITRM20130174A1 (it) * 2013-03-22 2014-09-23 Eurospital S P A Ceppo di lactobacillus e suo uso come probiotico
BR112016002650A2 (pt) * 2013-08-09 2017-09-12 Ab Biotics Sa probiótico para choro excessivo infantil
ITMI20131467A1 (it) 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
WO2015042683A1 (en) * 2013-09-26 2015-04-02 Hassan Firoozmand Biopolymer compositions comprising a plurality of treated single-celled microorganisms
KR102240196B1 (ko) * 2014-03-24 2021-04-15 오츠카 세이야쿠 가부시키가이샤 신규한 락토바실러스 파라카세이 균주
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
RU2605626C2 (ru) * 2015-04-28 2016-12-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский технологический институт пищевой промышленности (университет)" Способ получения бактериального препарата с пробиотической активностью
CN114159476A (zh) 2015-05-14 2022-03-11 克雷斯顿沃控股公司 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
CN114366759A (zh) 2015-05-22 2022-04-19 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
CN104894021B (zh) * 2015-06-03 2018-02-09 宜兰食品工业股份有限公司 一种副干酪乳杆菌及其应用
CN105176822B (zh) * 2015-10-23 2019-01-11 广州康泽医疗科技有限公司 一种人类肠道益生菌的优化分离方法
ITUA20164188A1 (it) 2016-06-08 2017-12-08 Sofar Spa Nuovo uso medico di probiotici
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
CN110996917A (zh) 2017-05-26 2020-04-10 克雷斯顿沃控股公司 包含基于粪便微生物的治疗剂的冻干组合物及其制造和使用方法
KR20200038506A (ko) 2017-08-07 2020-04-13 핀치 테라퓨틱스, 인코포레이티드 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
SG11202006428UA (en) * 2018-01-03 2020-08-28 Evolve Biosystems Inc Method for determining dysbiosis in the intestinal microbiome
ES2986025T3 (es) * 2018-01-05 2024-11-08 Bened Biomedical Co Ltd Bacteria de ácido láctico novedosa y sus aplicaciones
CN108315285A (zh) * 2018-05-08 2018-07-24 西藏高原之宝牦牛乳业股份有限公司 一种副干酪乳杆菌及其制备方法
CN111164201B (zh) * 2018-07-02 2023-09-12 葡萄王生技股份有限公司 用于改善代谢症候群的副干酪乳杆菌gks6、其用途、医药组合物及可食用组合物
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CN109134628A (zh) * 2018-09-26 2019-01-04 福建傲农生物科技集团股份有限公司 一种乳酸菌素plnE及其制备方法
CN113164527A (zh) 2018-09-27 2021-07-23 芬奇治疗控股有限责任公司 用于治疗癫痫和相关障碍的组合物和方法
CN109536415B (zh) * 2018-12-26 2021-12-07 江西仁仁健康产业有限公司 一种鼠李糖乳杆菌及其应用
BR112021007249A2 (pt) 2019-01-16 2021-08-10 N.V. Nutricia composições nutricionais
WO2020168306A1 (en) * 2019-02-14 2020-08-20 Gutsybio Inc. Live biotherapeutics for the treatment of carbohydrate disorders
EP3718416B1 (en) 2019-04-03 2024-05-29 COREE S.r.l. Production method to increase bioavailability of sugars from natural complex polysaccharides for human, animal and agricultural purposes
KR102139687B1 (ko) * 2019-05-03 2020-07-30 주식회사 메디오젠 가드네렐라 바기날리스 및 칸디다 알비칸스에 항균 효과를 갖는 질염 치료 또는 개선용 유산균 mg4288
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
JP7013419B2 (ja) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
IT201900020422A1 (it) * 2019-11-05 2021-05-05 Sofar Spa Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine
EP3725167A1 (en) * 2019-11-11 2020-10-21 COREE S.r.l. Synergistic blends of probiotics expressing improved beneficial activity for human host favourably interacting with food, particularly baby food
KR102296286B1 (ko) * 2020-06-16 2021-09-01 주식회사 바이오뱅크힐링 락토바실러스 람노서스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
WO2021242057A1 (ko) * 2020-05-28 2021-12-02 주식회사 바이오뱅크힐링 락토바실러스 속 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN113817622B (zh) * 2020-06-18 2023-05-26 青岛蔚蓝生物股份有限公司 一株具有减轻致癌物对人体细胞基因毒性作用的长双歧杆菌及其应用
CN111826312B (zh) * 2020-07-10 2022-03-25 江南大学 一株可缓解苯并芘暴露的鼠李糖乳杆菌及其应用
CN111733110B (zh) * 2020-07-17 2021-10-22 佛山市朗芯生物科技有限公司 副干酪乳杆菌及其在制备治疗溃疡性结肠炎药物中的应用
CN114317320B (zh) * 2020-08-24 2022-12-27 汤臣倍健股份有限公司 一种短双歧杆菌207-1及其应用
CN113265351B (zh) * 2021-05-11 2022-05-06 昆明理工大学 一株乳杆菌w8172及其应用
RU2766765C1 (ru) * 2021-05-25 2022-03-15 Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" Способ лечения функциональных заболеваний желудочно-кишечного тракта у детей
CN113322216B (zh) * 2021-07-30 2021-11-05 北京量化健康科技有限公司 一种副干酪乳杆菌b111h及其在代谢综合征中的应用
KR102562507B1 (ko) * 2021-12-08 2023-08-02 한국식품연구원 항염증 효과가 뛰어난 신규한 락토바실러스 파라카제이 아종 톨러란스 WiKim0148 및 이의 용도
CN114113023B (zh) * 2021-12-16 2024-04-26 郑州轻工业大学 基于单核增生李斯特菌来源的氮掺杂碳点的制备方法和应用
CN114292779A (zh) * 2021-12-22 2022-04-08 清远西周生物医药科技有限公司 一种副干酪乳杆菌冻干粉、其应用及制备方法
CN114381411B (zh) * 2022-03-23 2022-05-27 山东中科嘉亿生物工程有限公司 乳酸乳球菌jyll-60及其在制备提高免疫力的产品上的应用
CN115998777B (zh) * 2022-10-18 2023-11-17 汤臣倍健股份有限公司 副干酪乳杆菌207-27的用途
CN116731891B (zh) * 2022-12-07 2024-05-07 内蒙古科拓生物有限公司 一株短双歧杆菌b2798及其制备益生菌制剂的用途
EP4660294A4 (en) * 2023-02-01 2026-05-20 Beijing Sanyuan Foods Co Ltd LACTICASEIBACILLUS RHAMNOSUS DERIVATIVE OF BREAST MILK AND USE
CN116397001A (zh) * 2023-03-31 2023-07-07 江南大学 一种具有在人肠道中占据高丰度潜力双歧杆菌菌株的筛选方法
CN116396905B (zh) * 2023-04-08 2025-02-14 威凯海思(山东)生物工程有限公司 一种短双歧杆菌hc2953、菌剂及其应用
CN116855413B (zh) * 2023-07-07 2024-02-09 镇江远森医药科技有限公司 利用鼠李糖乳杆菌YSs069制备调节人体微生态平衡的生物活性物质及其应用
KR102700400B1 (ko) * 2023-11-24 2024-09-02 (주)마이크로바이옴 항균 활성 및 프로바이오틱스 특성을 갖는 글루텐 분해능이 있는 락토바실러스 파라카제이 glu70 균주 및 이의 용도
CN117660253B (zh) * 2023-12-10 2024-11-01 石河子大学 一种鼠李糖乳酪杆菌fmbl l23004 cnn、酸奶发酵剂、酸奶及其应用
PL248110B1 (pl) * 2023-12-27 2025-10-20 Politechnika Lodzka Szczep bakterii mlekowych Lacticaseibacillus rhamnosus
CN119193442B (zh) * 2024-11-29 2025-06-27 山东健源生物科技有限公司 一株可以清除机体内毒素的短双歧杆菌及其后生元
CN121046267B (zh) * 2025-10-31 2026-05-26 天赋能健康产业集团股份有限公司 短双歧杆菌在制备抗幽门螺杆菌导致的胃溃疡及胃部炎症的产品中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124060T5 (es) * 1992-07-06 2002-12-16 Nestle Sa Bacteria lactica.
EP1007625B1 (en) * 1997-08-21 2010-08-11 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
EP1178730B1 (en) * 1999-05-07 2005-03-23 Compagnie Gervais Danone Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP4740866B2 (ja) * 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
CN1259054C (zh) * 2004-12-27 2006-06-14 孙文基 龙胆苦苷在制备抑制乙型肝炎病毒药物中的应用
AU2006233918B2 (en) * 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
EP2269465A1 (en) * 2006-05-03 2011-01-05 Probiotical S.p.a. Compositions comprising Bifidobacterium adolescentis
US20100166721A1 (en) * 2006-06-09 2010-07-01 Fabiola Masri Probotic compositions and uses thereof
US8066986B2 (en) * 2007-02-01 2011-11-29 Master Supplements, Inc. Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis

Also Published As

Publication number Publication date
EP2848682A1 (en) 2015-03-18
RU2551315C2 (ru) 2015-05-20
DK2407532T3 (en) 2015-03-09
CN102421889A (zh) 2012-04-18
EP2407532A4 (en) 2013-04-10
EP2848682B1 (en) 2017-05-31
RU2011138363A (ru) 2013-04-20
WO2010103140A2 (es) 2010-09-16
CN104232545B (zh) 2017-11-21
EP2407532B1 (en) 2014-12-10
CN104232544B (zh) 2017-04-12
PL2848682T3 (pl) 2017-12-29
WO2010103140A3 (es) 2010-11-04
PL2407532T3 (pl) 2015-06-30
ES2636944T3 (es) 2017-10-10
CN104232544A (zh) 2014-12-24
US20130280789A1 (en) 2013-10-24
PL2848681T3 (pl) 2017-10-31
US20130280790A1 (en) 2013-10-24
US8637297B2 (en) 2014-01-28
US20120076829A1 (en) 2012-03-29
EP2407532A2 (en) 2012-01-18
DK2848681T3 (en) 2017-07-24
EP2848681A1 (en) 2015-03-18
CN102421889B (zh) 2014-10-29
DK2848682T3 (en) 2017-09-11
ES2532095T3 (es) 2015-03-24
EP2848681B1 (en) 2017-04-12
CN104232545A (zh) 2014-12-24
ES2632436T3 (es) 2017-09-13
WO2010103132A1 (es) 2010-09-16

Similar Documents

Publication Publication Date Title
PL2848682T3 (pl) Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym z kału niemowląt karmionych wyłącznie mlekiem matki
PL2429557T3 (pl) Preparaty do odżywiania niemowląt zawierające probiotyczne mikroorganizmy
SG175087A1 (en) Shelf-stable fermented dairy products and methods of making same
PL2340754T3 (pl) Urządzenie do wytwarzania spienionego mleka i tym podobnych spienionych substancji
EP2323494A4 (en) PROBIOTIC INFANT PRODUCTS
PL2323493T3 (pl) Produkty probiotyczne dla niemowląt
AP2011005838A0 (en) Process for the preparation of fischer-tropsch catalysts and their use.
PL2429305T3 (pl) Produkt mleczny i sposób
PL2498789T3 (pl) Probiotyczny szczep bifidobacterium
PL2789279T3 (pl) Układ do wytwarzania napojów, w szczególności napojów na bazie mleka takich jak cappuccino, czekolada i tym podobnych
GB2481169B (en) A reduced lactose milk product and a process for the preparation thereof
LT2632277T (lt) Pieno produktas ir gamybos būdas
ZA201409369B (en) Composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system
ZA201109072B (en) Probiotic juice drink
ZA201203668B (en) Pet food compositions including probiotics and methods of manufacturing and use thereof
PL2707478T3 (pl) Probiotyczne szczepy bakterii i zawierająca je kompozycja symbiotyczna przeznaczona do żywności dla niemowląt
PL2408311T3 (pl) Demineralizacja i frakcjonowanie serwatki lub surowego mleka
ZA201200162B (en) Carbonated drink comprising soybean flour or soybean milk
LT2429305T (lt) Pieno produktas ir būdas
ZA201105182B (en) Remote baby sitting monitor
GB201201046D0 (en) Container for dairy products and the like
PL388521A1 (pl) Sposób wytwarzania jogurtu z mleka niskolaktozowego
PL389279A3 (pl) Sposób wytwarzania jogurtu z mleka niskolaktozowego
GB201013293D0 (en) The baby milk kettle
PL387418A1 (pl) Preparat mineralno-bakteryjny i sposób jego otrzymywania